hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06280911 id: 098 briefTitle: The Effect of Consumption of Date Fruit and Nipple Stimulation in Late Pregnancy overallStatus: COMPLETED date: 2013-10-10 date: 2014-06-30 date: 2017-12-30 date: 2024-02-28 date: 2024-03-04 name: Selcuk University class: OTHER briefSummary: The study was conducted to determine the effect of consumption of date fruit and nipple stimulation on labor.
The samples were applied to pregnant women satisfying the research criteria in a state hospital in Istanbul between October 2013 and June 2014. conditions: Augmentation conditions: Induction conditions: Labor conditions: Stimulation, Self studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The study was designed to be randomly controlled. primaryPurpose: SUPPORTIVE_CARE masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 198 type: ACTUAL name: Date Fruit group name: Nipple group measure: The spontaneous onset of labor measure: Induction and augmentation of labor measure: Mode of delivery sex: FEMALE minimumAge: 18 Years maximumAge: 35 Years stdAges: ADULT facility: Zeynep Kamil Women's and Children's Diseases Training and Research Hospital city: Istanbul country: Turkey lat: 41.01384 lon: 28.94966 hasResults: False
nctId: NCT06280898 id: KC22RISI0395 briefTitle: Perioperative Factors and Early Postoperative Kidney Graft Function Recovery overallStatus: COMPLETED date: 2020-05-01 date: 2022-03-14 date: 2022-03-14 date: 2024-02-28 date: 2024-02-29 name: Seoul St. Mary's Hospital class: OTHER briefSummary: Divided into two groups based on acute kidney injury: non-acute kidney injury group vs. non-acute kidney injury group. Acute kidney injury group, Acute Kidney Injury Network (AKIN), Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE), or Kidney Disease: Improving Global Outcomes (KDIGO) I would like to divide it according to the definition. After testing the normal distribution of patients, donors, grafts, types of immunosuppressants, surgery/anesthesia factors, and blood test findings between the two groups through the Shapiro-Wilk test, continuous data was tested using the student t-test or Mann-Whitney U test. Sizes are compared using , and categorical data is compared with proportions using the χ2 test or Fisher's exact test. Analysis of factors related to acute kidney injury will be performed through univariate and multivariate logistic regression analysis. conditions: Heart Injuries conditions: Kidney Transplant; Complications studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 539 type: ACTUAL name: Remote ischemic conditioning measure: Troponin I measure: Troponin T measure: QTc interval sex: ALL minimumAge: 19 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Seoul St. Mary's hospital city: Seoul zip: 06591 country: Korea, Republic of lat: 37.566 lon: 126.9784 hasResults: False
nctId: NCT06280885 id: FIERCE briefTitle: A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy acronym: FIERCE overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2025-09-01 date: 2026-03-31 date: 2024-02-28 date: 2024-02-28 name: University of Dublin, Trinity College class: OTHER name: St. James's Hospital, Ireland briefSummary: The primary aim of this study is to measure the feasibility of delivering a co-designed exercise programme for patients with cancer receiving chemotherapy treatment. conditions: Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Feasibility randomised controlled trial using a 2:1 randomisation primaryPurpose: SUPPORTIVE_CARE masking: NONE maskingDescription: Not indicated for this feasibility study. count: 50 type: ESTIMATED name: Exercise name: Health Behaviour Change (Pedometer) measure: Feasibility: Recruitment rates measure: Feasibility: Adherence rates measure: Feasibility: Attendance rates measure: Feasibility: Retention Rates measure: Feasibility: Reason for drop0out measure: Cardiorespiratory Fitness measure: Muscular Strength measure: Body Mass Index measure: Mid-arm circumference measure: Waist Circumference measure: Bioimpedance Analysis measure: Health Related Quality of Life measure: Fatigue sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: St James's Hospital city: Dublin zip: 8 country: Ireland lat: 53.33306 lon: -6.24889 hasResults: False
nctId: NCT06280872 id: P2023/Neonat/PhyCordPrem briefTitle: Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns acronym: PhyCordPrem overallStatus: RECRUITING date: 2024-02-19 date: 2026-01 date: 2026-07 date: 2024-02-28 date: 2024-03-05 name: Queen Fabiola Children's University Hospital class: OTHER name: The Belgian Kids Fund name: Fonds IRIS-Recherche name: Ars Statistica briefSummary: Before birth, the baby's lungs are filled with fluid and babies do not use the lungs to breathe, as the oxygen comes from the placenta. As delivery approaches, the lungs begin to absorb the fluid. After vaginal delivery, the umbilical cord is clamped and cut after a delay that allows some of the blood in the umbilical cord and placenta to flow back into the baby. Meanwhile, as the baby breathes for the first time, the lungs fill with air and more fluid is pushed out. However, it does not always work out that way.
nctId: NCT06280859 id: 18784 briefTitle: Hoosier Sport: Developing and Implementing a Sustainable Campus-Community Partnership in Rural Indiana overallStatus: ACTIVE_NOT_RECRUITING date: 2024-02-20 date: 2024-05-30 date: 2024-06-10 date: 2024-02-28 date: 2024-03-15 name: Indiana University class: OTHER name: United States Department of Agriculture (USDA) briefSummary: The clinical trial aims to develop and pilot test a multilevel physical activity (PA) intervention called the Hoosier Sport program. The study follows a participatory co-design protocol involving youth, parents, and community leaders to provide direct input into the intervention's design. The ultimate goal is to contribute to health equity in the community by promoting sustainable physical activity. Hoosier Sport involves delivering enhanced physical education classes, teaching about nutrition and exercise, as well as developing leadership skills in middle school rural students.The intervention will last for 8-weeks with PE classes occur twice a week. Additionally, Hoosier Sport will create more opportunities for students to be active at school (e.g., in home room) through providing virtual classes and other activities. conditions: Cardiovascular Diseases conditions: Sedentary Behavior studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Students enrolled in physical education (PE) class will be eligible to enroll in the study, and serve as the intervention group. Those not enrolled in PE that semester will be recruited as the control group. primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 34 type: ACTUAL name: Hoosier Sport measure: Feasibility of Intervention Measure (FIM) measure: Acceptability of Intervention Measure (IAM) measure: Intervention Appropriateness Measure (AIM) measure: Daily Steps of Participants measure: Daily Moderate to Vigorous Physical Activity of Participants measure: Heart Rate of Participants measure: Blood Pressure of Participants measure: Basic Psychological Needs of Participants in Intervention Environment measure: Physical Literacy of Participants measure: Cardiovascular Fitness Levels of Participants measure: Muscular Endurance Levels of Participants measure: Self-Reported Weekly Moderate to Vigorous Physical Activity of Participants measure: Nutrition Knowledge of Participants measure: Policy, Systems, and Environmental Factors Influencing Participant Physical Activity and Nutrition Behavior. sex: ALL minimumAge: 9 Years maximumAge: 15 Years stdAges: CHILD facility: Indiana University city: Bloomington state: Indiana zip: 47405 country: United States lat: 39.16533 lon: -86.52639 hasResults: False
nctId: NCT06280846 id: P.T.REC/012/004878 briefTitle: High-intensity Versus Low-intensity Laser Acupuncture in Chronic, Non-specific Low Back Pain overallStatus: RECRUITING date: 2024-03-15 date: 2024-10-30 date: 2024-10-30 date: 2024-02-28 date: 2024-04-26 name: Cairo University class: OTHER name: King Khalid University briefSummary: The purpose of this study is to investigate the efficacy of high-intensity laser acupuncture versus low intensity laser acupuncture on peak torque of trunk extensors, fatigue of trunk extensors, back pain, ROM and function in patients with chronic nonspecific low back pain (CNLBP). conditions: Chronic Nonspecific Low-back Pain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: high-intensity laser acupuncture, low-intensity laser acupuncture and exercise therapy program primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: random generator whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: high-intensity laser acupuncture and Exercise therapy program name: low-intensity laser acupuncture and Exercise therapy program name: Sham laser acupuncture measure: peak torque measure: peak torque measure: Fatigue measure: Fatigue measure: Pain Intensity measure: Pain Intensity measure: lumbar flexion ROM assessment measure: lumbar flexion ROM assessment measure: Disability measure: Disability sex: ALL minimumAge: 20 Years maximumAge: 40 Years stdAges: ADULT facility: Doaa Ayoub Elimy status: RECRUITING city: Giza zip: 11251 country: Egypt name: Doaa A Elimy, lecturer role: CONTACT phone: 00201066474654 email: do3aayoub25@gmail.com lat: 30.00808 lon: 31.21093 hasResults: False
nctId: NCT06280833 id: 10001884 id: 001884-HG briefTitle: Care Choreographies and the Making of the Psychosocial in Genetic Counseling overallStatus: RECRUITING date: 2024-05-01 date: 2024-10-01 date: 2024-10-01 date: 2024-02-28 date: 2024-04-26 name: National Human Genome Research Institute (NHGRI) class: NIH briefSummary: Background:
Participants will have only 1 session with the investigator. Counselors may have 4 to 10 sessions with an investigator over 8 months. conditions: Genetic Counselor studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 250 type: ESTIMATED measure: Care sex: ALL minimumAge: 18 Years maximumAge: 115 Years stdAges: ADULT stdAges: OLDER_ADULT facility: National Human Genome Research Institute (NHGRI) status: RECRUITING city: Bethesda state: Maryland zip: 20892 country: United States name: Sara Hull, Ph.D. role: CONTACT phone: 301-435-8712 email: shull@nhgri.nih.gov lat: 38.98067 lon: -77.10026 hasResults: False
nctId: NCT06280820 id: 10001889 id: 001889-H briefTitle: Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART) overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2028-04-30 date: 2034-04-30 date: 2024-02-28 date: 2024-04-26 name: National Heart, Lung, and Blood Institute (NHLBI) class: NIH briefSummary: Background:
Researchers will follow the participants health by monitoring their medical records for up to 5 years. conditions: Heart Failure studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 2000 type: ESTIMATED measure: To study the association between multi-omics signatures with all-cause mortality measure: Clinical phenotypes defined by:Ejection Fraction (>=50 vs. < 50)NYHA (3-4 vs. 1-2) measure: To study the cross-sectional association between multi-omics signatures with clinical sub-phenotypes of heart failure sex: ALL minimumAge: 18 Years maximumAge: 100 Years stdAges: ADULT stdAges: OLDER_ADULT facility: National Heart, Lung and Blood Institute (NHLBI) city: Bethesda state: Maryland zip: 20892 country: United States name: Veronique Roger, M.D. role: CONTACT phone: 301-402-1715 email: veronique.roger@nih.gov lat: 38.98067 lon: -77.10026 hasResults: False
nctId: NCT06280807 id: 10001617 id: 001617-E briefTitle: Observation of Environment and Reproductive-Endocrine Effects overallStatus: RECRUITING date: 2024-05-01 date: 2039-03-28 date: 2039-03-31 date: 2024-02-28 date: 2024-04-26 name: National Institute of Environmental Health Sciences (NIEHS) class: NIH briefSummary: Background:
... conditions: Hypogonadism conditions: Hypergonadism conditions: Precocious Puberty conditions: Late Puberty conditions: Amenorrhea studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 300 type: ESTIMATED measure: Investigate the relationship between environment, lifestyle, and reproductive neuroendocrinology. measure: the relationship between nutrition, diet and reproduction measure: the impact of stress on reproductive dysfunction measure: the influence of behavioral and psychological factors on reproductive function sex: ALL minimumAge: 8 Years maximumAge: 99 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: NIEHS Clinical Research Unit (CRU) status: RECRUITING city: Research Triangle Park state: North Carolina zip: 27709 country: United States name: NIH Clinical Center Office of Patient Recruitment (OPR) role: CONTACT phone: 800-411-1222 phoneExt: TTY dial 711 email: ccopr@nih.gov name: NIEHS Join A Study Recruitment Group role: CONTACT phone: (855) 696-4347 email: myniehs@nih.gov lat: 35.90567 lon: -78.90497 hasResults: False
nctId: NCT06280794 id: Laser-Bell-2024 briefTitle: Efficacy of Laser Acupuncture for Idiopathic Bell's Palsy overallStatus: COMPLETED date: 2022-03-01 date: 2024-01-01 date: 2024-02-01 date: 2024-02-28 date: 2024-03-29 name: Beijing Tongren Hospital class: OTHER briefSummary: Objective:
Clinical outcome measure comprised the House-Brackmann grading system, Facial Clinimetric Evaluation Scale (FaCE), Sunnybrook facial grading scale (SBFG), Facial Disability Index (FDI) and Facial Clinimetric Evaluation Scale (FaCE Scale) All the measurements were collected at the baseline, weeks 2, 4, 6, 8, 12 and 24. conditions: Bell's Palsy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 336 type: ACTUAL name: Laser acupuncture name: Steroids measure: House Brackmann Grading System (HB) measure: Sunnybrook Facial Grading Scale (SB Grading) measure: Facial Disability Index (FDI) measure: Facial Clinimetric Evaluation Scale (FaCE Scale) sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Beijing TongRen Hospital, Capital Medical University city: Beijing country: China lat: 39.9075 lon: 116.39723 hasResults: False
nctId: NCT06280781 id: 22CX7971 id: NIHR152027 type: OTHER_GRANT domain: National Institute of Health Research - Health Technology Assessment briefTitle: Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance) acronym: IP9-ATLAS overallStatus: NOT_YET_RECRUITING date: 2024-07 date: 2029-06 date: 2032-06 date: 2024-02-28 date: 2024-02-28 name: Imperial College Healthcare NHS Trust class: OTHER name: East London NHS Foundation Trust name: King's College name: University College, London name: University of York name: University College London Hospitals briefSummary: The goal of this intervention study is for patients on active surveillance for prostate cancer, to demonstrate that use of regular MRI scans is better able to detect cancer progression over 5 years compared to the current NICE defined strategy.
Patients will be allocated in a 1.1 ratio to either MRI scans or the current NICE defined standard. Randomisation will be blocked (random block size) and stratified by MRI visibility of lesions (3 categories \[ no visible lesion, diffuse changes, discrete visible lesion\]), cancer Grade Group (GG1, GG2) and time since diagnosis. This study will not be blinded to patients or physicians. conditions: Prostate Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: FACTORIAL interventionModelDescription: Current (NICE defined active surveillance):
Patients with a visible lesion or medium risk cancer will have PSA 6 monthly and MRI annually. All other patients will undergo PSA 6 monthly and MRI in years 1, 3 and 5. In all patients, a targeted biopsy will be carried out if the MRI PRECISE score is \>/=4. primaryPurpose: OTHER masking: NONE count: 1263 type: ESTIMATED name: MRI Scans measure: Biopsy measure: Staging measure: Cost-effectiveness measure: Biopsy Measurement measure: MRI & biopsy-related adverse events measure: Treatment measure: Compliance measure: EPIC Questionnaires measure: HADS Questionnaires measure: EQ-5D-5L Questionnaires sex: MALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT typeAbbrev: Prot_SAP hasProtocol: True hasSap: True hasIcf: False label: Study Protocol and Statistical Analysis Plan date: 2023-12-07 uploadDate: 2024-01-24T08:54 filename: Prot_SAP_000.pdf size: 1231033 typeAbbrev: ICF hasProtocol: False hasSap: False hasIcf: True label: Informed Consent Form date: 2023-12-07 uploadDate: 2024-01-24T09:01 filename: ICF_001.pdf size: 286927 hasResults: False
nctId: NCT06280768 id: SHR-2004-102 briefTitle: Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2024-12-31 date: 2024-12-31 date: 2024-02-28 date: 2024-02-28 name: Beijing Suncadia Pharmaceuticals Co., Ltd class: INDUSTRY briefSummary: This study is an open-label Phase Ib clinical study with the primary objective of evaluating the safety and tolerability of multiple subcutaneous injections of SHR-2004 injection in patients with atrial fibrillation, and the secondary objective is to evaluate its pharmacokinetic (PK), pharmacodynamic (PD) and immunogenicity characteristics. conditions: Atrial Fibrillation studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 48 type: ESTIMATED name: SHR-2004 injection measure: Incidence and severity of adverse events (including bleeding events) measure: Pharmacokinetics of SHR2004: Peak Plasma Concentration (Cmax) measure: Pharmacokinetics of SHR2004: Area under the plasma concentration versus time curve (AUC) measure: Pharmacokinetics of Dupilumab: Elimination half life (t1/2) measure: PD endpoint: absolute and relative change values of coagulation factor XI (FXI) activity measure: PD endpoint: absolute and relative change values of activated partial thromboplastin time (APTT) measure: Immunogenicity endpoint: the incidence and timing of ADA positivity in SHR-2004 sex: ALL minimumAge: 40 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06280742 id: APHP221366 briefTitle: Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET) acronym: INFLANET overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2026-03-01 date: 2026-03-01 date: 2024-02-28 date: 2024-04-29 name: Assistance Publique - Hôpitaux de Paris class: OTHER briefSummary: The Service Hospitalier Frédéric-Joliot (SHFJ) and Paris Brain Institute (ICM) groups have identified \[18F\]-DPA-714 as a promising second-generation TSPO tracer, a macromolecule overexpressed in neuroinflammatory conditions, for PET imaging. They have also developed a non-invasive quantification methodology, enabling the generation of individual neuroinflammation maps in MS patients. Recent findings from \[18F\]-DPA-714 PET imaging in MS patients revealed that most of the white matter lesions contained a smoldering component, even when considered inactive on MRI, and that their neuroinflammatory profiles were associated with longitudinal disability worsening. The Inflanet project aims to leverage a unique consortium comprising French radiochemists, radiopharmacists, nuclear medicine/neuroimaging experts, and MS neurologists to establish the first national network dedicated to \[18F\]-DPA-714 PET imaging in MS, so far limited to monocentric studies.
The objectives of the INFLANET project are (1) to conduct the first multicenter study assessing neuroinflammation in patients with active MS using \[18F\]DPA-714 PET tracer, and (2) to establish a methodology suitable for the quantification of multicenter PET data obtained with \[18F\]DPA-714. The INFLANET initiative aims to disseminate TSPO PET within the French MS research community, thereby opening the unique perspective of future large-scale, multicenter studies. These endeavors are expected to enhance our capacity to predict diseases, stratify patients, and assess new therapeutic interventions. conditions: Multiple Sclerosis studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: NONE count: 41 type: ESTIMATED name: PET-MRI with [18F]-DPA-714 measure: To quantify the smoldering component of white matter lesions in people with MS, as compared with [18F]-DPA-714 binding in the white matter of HC who underwent a PET a acquisition with the same camera camera than patients in each center. measure: To quantify for each patient the regional neuroinflammatory load, measured as [18F]-DPA-714 DVR, in specific regions of interest: total brain, normal appearing white matter, cortex, thalami, deep grey matter. measure: The MRI signatures of each lesional subtypes, and correlation between MRI metrics and [18F]-DPA-714 DVR in each region of interest. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Département de Neurologie,Pierre Wertheimer Neurological Hospital city: Lyon zip: 69500 country: France name: Françoise DURAND-DUBIEF, MD role: CONTACT phone: 04 72 35 75 22 phoneExt: +33 email: francoise.durand-dubief@chu-lyon.fr lat: 45.74848 lon: 4.84669 facility: CERMEP city: Lyon zip: 69677 country: France name: Françoise DURAND-DUBIEF, MD role: CONTACT phone: 04 72 35 75 22 phoneExt: +33 email: francoise.durand-dubief@chu-lyon.fr lat: 45.74848 lon: 4.84669 facility: CIC Neurosciences, GH Pitié-Salpêtrière city: Paris zip: 75013 country: France name: Bruno Stankoff, MD role: CONTACT phone: 0171970659 phoneExt: +33 email: bruno.stankoff@aphp.fr lat: 48.85341 lon: 2.3488 facility: Centre Eugène Marquis city: Rennes zip: 35000 country: France name: Xavier Palard, MD role: CONTACT phone: 02 99 25 30 83 phoneExt: +33 email: x.palard@rennes.unicancer.fr lat: 48.11198 lon: -1.67429 facility: Service de Neurologie, CHU Pontchaillou city: Rennes zip: 35000 country: France name: Anne Kerbrat, MD role: CONTACT phone: 02 99 28 42 94 phoneExt: +33 email: anne.kerbrat@chu-rennes.fr lat: 48.11198 lon: -1.67429 hasResults: False
nctId: NCT06280729 id: AI-TRYDIA briefTitle: AI-Predicted Disease Trajectories in Diabetes: A Retrospective Study acronym: AI-TRYDIA overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2025-03-01 date: 2026-03-01 date: 2024-02-28 date: 2024-02-28 name: IRCCS San Raffaele class: OTHER briefSummary: The study explores the utilization of artificial intelligence (AI) to predict disease progression trajectories in patients with diabetes. By analyzing historical data from a retrospective cohort, we aim to identify patterns and predictors of disease evolution. The approach seeks to enhance personalized treatment strategies and improve outcomes by foreseeing potential complications and disease milestones. The findings could pave the way for more targeted and effective management of diabetes through AI-driven insights. conditions: Diabetes Mellitus, Type 1 conditions: Diabetes Mellitus, Type 2 studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: RETROSPECTIVE count: 10000 type: ESTIMATED name: AI-Analyis measure: Primary Endpoint measure: Primary Endpoint measure: Primary Endpoint measure: Exploratory Objectives sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Diabetes Research Institute-IRCCS Ospedale San Raffaele city: Milan state: Lombardy zip: 20132 country: Italy lat: 45.46427 lon: 9.18951 hasResults: False